Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 3, 2011, Pages

  Harding, Pamela ^a   Yang, Xiao Ping ^a   He, Quan ^a   LaPointe, Margot C ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Angiotensin II; Hypertrophy; Microsomal prostaglandin E synthase 1

Indexed keywords

ANGIOTENSIN II; COLLAGEN; PROSTAGLANDIN E SYNTHASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; C57BL 6 MOUSE; CONTROLLED STUDY; DIASTOLE; ENZYME DEFICIENCY; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART STRESS; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; M MODE ECHOCARDIOGRAPHY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SYSTOLE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; CARDIOMEGALY; ECHOCARDIOGRAPHY; HYPERTENSION; INTRAMOLECULAR OXIDOREDUCTASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSOMES; MYOCYTES, CARDIAC; VENTRICULAR FUNCTION;

EID: 79955053753     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00772.2010     Document Type: Article

References (31)

1. 4 overexpression and unstable phenotype in atherosclerotic plaques in human. Arterioscler Thromb Vasc Biol 25: 1925-1931, 2005.
2. Degousee N, Fazel S, Angoulvant D, Stefanski E, Pawelzik SC, Korotkova M, Arab S, Liu P, Lindsay TF, Zhuo S, Butany J, Li RK, Audoly L, Schmidt R, Angioni C, Geisslinger G, Jakobsson PJ, Rubin BB. Microsomal prostaglandin E2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarction. Circulation 117: 1701-1710, 2008.
3. Facemire CS, Griffiths R, Audoly LP, Koller BH, Coffman TM. The impact of microsomal prostaglandin e synthase 1 on blood pressure is determined by genetic background. Hypertension 55: 531-538, 2010.
4. Frias MA, Somers S, Gerber-Wicht C, Opie LH, Lecour S, Lang U. The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis. Cardiovasc Res 80: 69-77, 2008.
5. Fujita M, Ando K, Nagae A, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension 50: 360-367, 2007.
6. Giannico G, Mendez M, LaPointe MC. Regulation of the membranelocalized prostaglandin E synthases mPGES-1 and mPGES-2 in cardiac myocytes and fibroblasts. Am J Physiol Heart Circ Physiol 288: H165-H174, 2005.
7. Gomez-Hernandez A, Martin-Ventura JL, Sanchez-Galan E, Vidal C, Ortego M, Blanco-Colio LM, Ortega L, Tunon J, Egido J. Overexpression of COX-2, Prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: regulation by nuclear factor-kappaB. Atherosclerosis 187: 139-149, 2006.
8. 4 knockout mice. Am J Physiol Heart Circ Physiol 298: H623-H632, 2010.
9. 4 signaling in neonatal ventricular myocytes. Am J Physiol Heart Circ Physiol 298: H136-H143, 2010.
10. Hickson-Bick DL, Jones C, Buja LM. The response of neonatal rat ventricular myocytes to lipopolysaccharide-induced stress. Shock 25: 546-552, 2006.
11. Hoggatt J, Singh P, Sampath J, Pelus LM. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 113: 5444-5455, 2009.
12. Jaimes EA, Tian RX, Pearse D, Raij L. Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. Kidney Int 68: 2143-2153, 2005.
13. Jia Z, Aoyagi T, Yang T. mPGES-1 protects against DOCA-salt hypertension via inhibition of oxidative stress or stimulation of NO/cGMP. Hypertension 55: 539-546, 2010.
14. Jia Z, Guo X, Zhang H, Wang MH, Dong Z, Yang T. Microsomal prostaglandin synthase-1-derived prostaglandin E2 protects against angiotensin II-induced hypertension via inhibition of oxidative stress. Hypertension 52: 952-959, 2008.
15. Kamei D, Yamakawa K, Takegoshi Y, Mikami-Nakanishi M, Nakatani Y, Oh-Ishi S, Yasui H, Azuma Y, Hirasawa N, Ohuchi K, Kawaguchi H, Ishikawa Y, Ishii T, Uematsu S, Akira S, Murakami M, Kudo I. Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1. J Biol Chem 279: 33684-33695, 2004.
16. Kawada N, Dennehy K, Solis G, Modlinger P, Hamel R, Kawada JT, Aslam S, Moriyama T, Imai E, Welch WJ, Wilcox CS. TP receptors regulate renal hemodynamics during angiotensin II slow pressor response. Am J Physiol Renal Physiol 287: F753-F759, 2004.
17. Kojima F, Kato S, Kawai S. Prostaglandin E synthase in the pathophysiology of arthritis. Fundam Clin Pharmacol 19: 255-261, 2005.
18. LaPointe MC, Mendez M, Leung A, Tao Z, Yang XP. Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse. Am J Physiol Heart Circ Physiol 286: H1416-H1424, 2004.
19. Lee KS, Lee HJ, Ahn KS, Kim SH, Nam D, Kim DK, Choi DY, Ahn KS, Lu J, Kim SH. Cyclooxygenase-2/prostaglandin E2 pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells. Cancer Lett 280: 93-100, 2009.
20. Maher TM, Evans IC, Bottoms SE, Mercer PF, Thorley AJ, Nicholson AG, Laurent GJ, Tetley TD, Chambers RC, McAnulty RJ. Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 182: 73-82, 2010.
21. 4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation. Am J Physiol Heart Circ Physiol 288: H2111-H2117, 2005.
22. Oliveira-Sales EB, Dugaich AP, Carillo BA, Abreu NP, Boim MA, Martins PJ, D'Almeida V, Dolnikoff MS, Bergamaschi CT, Campos RR. Oxidative stress contributes to renovascular hypertension. Am J Hypertens 21: 98-104, 2008.
23. 4 receptor knockout mice with myocardial infarction. Hypertension 51: 560-566, 2008.
24. Saito T, Rodger IW, Hu F, Shennib H, Giaid A. Inhibition of cyclooxygenase-2 improves cardiac function in myocardial infarction. Biochem Biophys Res Commun 273: 772-775, 2000.
25. Siragy HM, Senbonmatsu T, Ichiki T, Inagami T, Carey RM. Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor. J Clin Invest 104: 181-188, 1999.
26. Streicher JM, Kamei K, Ishikawa TO, Herschman H, Wang Y. Compensatory hypertrophy induced by ventricular cardiomyocyte-specific COX-2 expression in mice. J Mol Cell Cardiol 49: 88-94, 2010.
27. Trebino CE, Eskra JD, Wachtmann TS, Perez JR, Carty TJ, Audoly LP. Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages. J Biol Chem 280: 16579-16585, 2005.
28. Trebino CE, Stock JL, Gibbons CP, Naiman BM, Wachtmann TS, Umland JP, Pandher K, Lapointe JM, Saha S, Roach ML, Carter D, Thomas NA, Durtschi BA, McNeish JD, Hambor JE, Jakobsson PJ, Carty TJ, Perez JR, Audoly LP. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci USA 100: 9044-9049, 2003.
29. Winer J, Jung CK, Shackel I, Williams PM. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270: 41-49, 1999.
30. Wu D, Mennerich D, Arndt K, Sugiyama K, Ozaki N, Schwarz K, Wei J, Wu H, Bishopric NH, Doods H. Comparison of microsomal prostaglandin E synthase-1 deletion and COX-2 inhibition in acute cardiac ischemia in mice. Prostaglandins Other Lipid Mediat 90: 21-25, 2009.
31. Zhang DJ, Chen LH, Zhang YH, Yang GR, Dou D, Gao YS, Zhang XY, Kong XM, Zhao P, Pu D, Wei MF, Breyer MD, Guan YF. Enhanced pressor response to acute ANG II infusion in mice lacking membrane-associated prostaglandin E2 synthase-1. Acta Pharmacol Sin 31: 1284-1292, 2010.